Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Accord Healthcare, Inc. recalls Levothyroxine Sodium Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.
Products
  • Levothyroxine Sodium Tablets
Where it was sold

Nationwide in the US

Nationwide

Units affected
54,432 bottles
About this recall
Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-15.